Literature DB >> 1331762

Consequences of 6-thioguanine incorporation into DNA on polymerase, ligase, and endonuclease reactions.

Y H Ling1, J Y Chan, K L Beattie, J A Nelson.   

Abstract

The incorporation of 6-thioguanine (S6G) in place of guanine proceeds readily in DNA synthesis reactions catalyzed by mammalian and bacterial polymerases. This report summarizes the consequences of such incorporation studied to date. S6G was incorporated into one strand of a defined M13mp18 phage sequence in a (+)reaction catalyzed by the Klenow fragment of Escherichia coli DNA polymerase I. After denaturation of the newly synthesized strand (containing S6G) and annealing with a reverse (-) 32P-labeled primer, polymerization catalyzed by the Klenow enzyme as well as by human DNA polymerases alpha, gamma, and delta was slowed considerably, compared with that across the corresponding guanine-containing template. To evaluate S6G-containing DNA as a substrate for DNA ligases, two oligodeoxynucleotides (19- and 20-mers) antisense to a 40-mer were synthesized so that the 40-mer coded for guanine at the 3' terminus of the 19-mer. After annealing of the synthetic oligonucleotides to form a duplex DNA containing a one-nucleotide gap (opposite cytosine in the 40-mer), the 19-mer was extended with 2'-deoxythioguanosine 5'-triphosphate using DNA polymerase, forming a nicked duplex DNA. The abilities of T4 DNA ligase and HeLa and calf thymus DNA ligase I to join the 5'-phosphate with the 3'-S6G-OH were severely inhibited, compared with the 3'-guanine-extended control. This finding suggests that incorporation of S6G at the 3' terminus of Okazaki fragments would inhibit lagging strand DNA synthesis. In other experiments, cleavage of S6G-containing DNA by some but not all restriction endonucleases progressed poorly, compared with the control guanine-containing DNA, independently of the location of S6G at recognition or cleavage sites, as previously observed by Iwaniec et al. [Mol. Pharmacol. 39:299-306 (1991)] with a different spectrum of enzymes. These findings indicate altered DNA-protein interactions due to S6G incorporation. The poor template function of S6G-containing DNA is consistent with the known delayed cytotoxicity and DNA damage previously reported to occur in S6G-treated cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331762

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

1.  Structural effect of the anticancer agent 6-thioguanine on duplex DNA.

Authors:  Jen Bohon; Carlos R de los Santos
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

Review 2.  Adverse events in IBD: to stop or continue immune suppressant and biologic treatment.

Authors:  Leon P McLean; Raymond K Cross
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-02-04       Impact factor: 3.869

3.  Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment.

Authors:  Gianluigi Zaza; Meyling Cheok; Wenjian Yang; John C Panetta; Ching-Hon Pui; Mary V Relling; William E Evans
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

4.  6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo.

Authors:  Hongxia Wang; Yinsheng Wang
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

5.  Mutations at serine 37 in mouse guanylate kinase confer resistance to 6-thioguanine.

Authors:  Andressa Ardiani; Amanda Goyke; Margaret E Black
Journal:  Protein Eng Des Sel       Date:  2009-01-10       Impact factor: 1.650

6.  Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R).

Authors:  Milica Pesić; Tijana Andjelković; Jasna Banković; Ivanka D Marković; Ljubisa Rakić; Sabera Ruzdijić
Journal:  Invest New Drugs       Date:  2008-05-21       Impact factor: 3.850

Review 7.  Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer.

Authors:  Jaehyun Kim; Linda A Feagins
Journal:  Dig Dis Sci       Date:  2019-11-11       Impact factor: 3.199

8.  Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.

Authors:  María Gómez-García; Maria José Cabello-Tapia; Antonio Damián Sánchez-Capilla; Javier De Teresa-Galván; Eduardo Redondo-Cerezo
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

9.  The effect of 6-thioguanine on alternative splicing and antisense-mediated exon skipping treatment for duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Annemieke Aartsma-Rus
Journal:  PLoS Curr       Date:  2012-12-12

10.  Properties of pseudo-complementary DNA substituted with weakly pairing analogs of guanine or cytosine.

Authors:  Georges Lahoud; Victor Timoshchuk; Alexandre Lebedev; Khalil Arar; Ya-Ming Hou; Howard Gamper
Journal:  Nucleic Acids Res       Date:  2008-11-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.